FindTrial
Sign In

The Analgesic and Anti-inflammatory Effects of Ultrasound-Guided Thoracic Paravertebral Block with Liposomal Bupivacaine After Thoracoscopic Surgery

The Analgesic and Anti-inflammatory Effects of Ultrasound-Guided Thoracic Paravertebral Block with Liposomal Bupivacaine After Thoracoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123132
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-04-27
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Ropivacaine group:Thoracic paravertebral block
Liposomal bupivacaine group:Thoracic paravertebral block

Sponsors

Weifang Yidu Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-70 years undergoing thoracoscopic lobectomy, American Society of Anesthesiologists ?-?;

Exclusion criteria

Exclusion criteria: 1. Allergy to study drugs, contraindications to nerve block, long-term oral opioids, severe liver disease, severe kidney disease, and communication disorders;

Design outcomes

Primary

MeasureTime frame
Total opioid consumption within the first 24 hours postoperativel;—

Countries

China

Contacts

Public ContactChu Wei

Weifang Yidu Central Hospital

1265493005@qq.com+86 536 3567701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026